US FDA inspection of its Goa plant ends with five observations

What happened

• The US Food and Drug Administration inspected Unichem Laboratories' formulations plant at Pilerne, Bardez, in Goa from 21 to 26 September 2026.
• The inspection ended with five observations, which the company says relate to procedural improvements.
• Unichem says there were no findings on data integrity or product quality, and that it will send its response to the FDA within the 15-day period.

Why it matters

Observations at the end of an FDA inspection are points the inspectors want fixed; they are not a final decision on the plant. The FDA looks at the company's response before deciding the outcome of the inspection.

Good to know: The FDA records inspection observations on a document called Form 483. Plants that make medicines for the US market are inspected regularly.

Key facts

Inspection

21 to 26 Sep 2026

Observations

5, procedural

Plant

Formulations, Pilerne (Goa)

Read the source

• Unichem Goa facility gets 5 USFDA observationsMedical Dialogues
• Unichem Laboratories USFDA inspection at Goa facility concludes with 5 procedural observationsSAHI